KETOROLAC

General Information

Brand: Ketorolac A.T®
Active Ingredient: Ketorolac Tromethamine
Strength: 30 mg / 2 ml (15 mg/ml)
Form: Sterile solution for injection
Administration: Intramuscular (IM) / Intravenous (IV)
Volume: 2 ml / ampoule
Packaging: 10 ampoules × 2 ml / box
Manufacturer: An Thien Pharmaceutical Joint Stock Company
Origin: Vietnam
Manufacturing Standard: WHO-GMP (as indicated on packaging)
Classification: Prescription medicine

Description

Ketorolac A.T® 30 mg is a prescription injectable medication containing ketorolac tromethamine, a potent non-steroidal anti-inflammatory drug (NSAID) formulated for the short-term management of moderate to severe acute pain.

Ketorolac works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins responsible for pain and inflammation.

Its injectable formulation provides an effective non-opioid analgesic option for patients requiring short-term parenteral pain management.

Each 2 ml ampoule contains 30 mg of ketorolac tromethamine and is intended for administration by qualified healthcare professionals.

Key Benefits

Potent Pain Relief: Provides effective analgesia for moderate to severe acute pain.

Non-Opioid Analgesic: Offers an alternative to opioid medications for appropriate acute pain conditions.

Anti-Inflammatory Action: Helps reduce prostaglandin-mediated inflammation and discomfort.

Injectable Formulation: Suitable for patients requiring parenteral pain management.

Dual Administration Routes: Can be administered intramuscularly or intravenously according to prescribing instructions.

Convenient Packaging: Each box contains 10 individually sealed 2 ml ampoules.

WHO-GMP Manufacturing: Packaging indicates compliance with WHO-GMP manufacturing standards.

Indications

• Short-term management of moderate to severe acute pain

• Postoperative pain requiring injectable analgesic treatment

• Acute musculoskeletal pain when clinically appropriate

• Other acute pain conditions requiring short-term NSAID therapy, as permitted by approved prescribing information

Treatment Protocol

Dosage: Individualized according to pain severity, patient age, body weight, kidney function, and clinical condition.

Administration: Intramuscular (IM) or intravenous (IV) injection by qualified healthcare professionals.

Treatment Duration: Ketorolac is intended for short-term treatment only. Total treatment duration, including any subsequent oral ketorolac, should not exceed 5 days where this limit applies under the approved prescribing information.

Monitoring: Assess pain response, renal function, gastrointestinal symptoms, and bleeding risk during treatment.

Important: Use the lowest effective dose for the shortest necessary duration.

Precautions

• Prescription medicine – for professional medical use only.

• Contraindicated in patients with active peptic ulcers, gastrointestinal bleeding, or a history of serious NSAID-related gastrointestinal complications.

• May increase the risk of gastrointestinal bleeding, ulceration, and perforation.

• Avoid use in patients with advanced renal impairment or those at risk of kidney failure due to dehydration.

• Do not combine with aspirin or other NSAIDs unless specifically authorized by a healthcare professional.

• Ketorolac inhibits platelet function and may increase bleeding risk.

• Avoid use in patients with known hypersensitivity to ketorolac or serious allergic reactions to aspirin or other NSAIDs.

• NSAID use during pregnancy carries important fetal risks, particularly from approximately 20 weeks onward.

• Use caution in elderly patients and individuals with cardiovascular, renal, or gastrointestinal risk factors.

• Store according to the manufacturer's instructions, protect from inappropriate storage conditions, and keep out of reach of children.

✨ Ketorolac A.T® 30 mg – Professional injectable ketorolac designed for effective, short-term management of moderate to severe acute pain under medical supervision.